Uploaded October 2025 | Updated September 2026, 2 weeks ago
Laura Dassama, PhD, assistant professor of microbiology and immunology and of chemistry, is developing a new type of therapy for patients who, like her, live with sickle cell disease, which is caused by a mutation in the gene that codes for hemoglobin, the protein responsible for the ability of red blood cells to carry oxygen. Dassama speaks to her experience with the illness and describes how her lab work takes inspiration from a form of hemoglobin active during fetal development, creating a new path of inquiry that she hopes will yield a new treatment for the condition.
Read more in Stanford Medicine magazine: https://stan.md/4nTlRYK
Explore more conversations on the Health Compass podcast: https://med.stanford.edu/health-compass-podcast.html
.
.
.
#SickleCellDisease #StanfordMedicine #HealthCompassPodcast #LauraDassama #MedicalResearch #Hemoglobin #GeneticDisorders #BloodDisorders #FetalHemoglobin #BiomedicalInnovation #GeneTherapy #ScienceForHealth #PatientScientist #Microbiology #Immunology #ChemistryResearch #HealthcareInnovation #TranslationalResearch #SciencePodcast
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.
The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.
Laura Dassama, PhD, assistant professor of microbiology and immunology and of chemistry, is developing a new type of therapy for patients who, like her, live with sickle cell disease, which is caused by a mutation in the gene that codes for hemoglobin, the protein responsible for the ability of red blood cells to carry oxygen. Dassama speaks to her experience with the illness and describes how her lab work takes inspiration from a form of hemoglobin active during fetal development, creating a new path of inquiry that she hopes will yield a new treatment for the condition.
Read more in Stanford Medicine magazine: https://stan.md/4nTlRYK
Explore more conversations on the Health Compass podcast: https://med.stanford.edu/health-compass-podcast.html
.
.
.
#SickleCellDisease #StanfordMedicine #HealthCompassPodcast #LauraDassama #MedicalResearch #Hemoglobin #GeneticDisorders #BloodDisorders #FetalHemoglobin #BiomedicalInnovation #GeneTherapy #ScienceForHealth #PatientScientist #Microbiology #Immunology #ChemistryResearch #HealthcareInnovation #TranslationalResearch #SciencePodcast
Stanford Medicine advances human health through world-class biomedical research, education and patient care. Bringing together the resources of Stanford University School of Medicine, Stanford Health Care and Lucile Packard Children's Hospital, Stanford Medicine is committed to training future leaders in biomedicine and translating the latest discoveries into new ways to prevent, diagnose and treat disease.
The Stanford Medicine YouTube channel is a curated collection of contributions from our School of Medicine departments, divisions, students, and the community. Our diverse content includes coverage of events, presentations, lectures, and associated stories about the people of Stanford Medicine.
